These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 31585083)

  • 1. Engineering Phage Host-Range and Suppressing Bacterial Resistance through Phage Tail Fiber Mutagenesis.
    Yehl K; Lemire S; Yang AC; Ando H; Mimee M; Torres MT; de la Fuente-Nunez C; Lu TK
    Cell; 2019 Oct; 179(2):459-469.e9. PubMed ID: 31585083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of tail fiber protein gp38 enables T2 phage to infect Escherichia coli O157:H7.
    Yoichi M; Abe M; Miyanaga K; Unno H; Tanji Y
    J Biotechnol; 2005 Jan; 115(1):101-7. PubMed ID: 15607229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Molecular and Genetic Basis of Repeatable Coevolution between Escherichia coli and Bacteriophage T3 in a Laboratory Microcosm.
    Perry EB; Barrick JE; Bohannan BJ
    PLoS One; 2015; 10(6):e0130639. PubMed ID: 26114300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A guard-killer phage cocktail effectively lyses the host and inhibits the development of phage-resistant strains of Escherichia coli.
    Yu L; Wang S; Guo Z; Liu H; Sun D; Yan G; Hu D; Du C; Feng X; Han W; Gu J; Sun C; Lei L
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):971-983. PubMed ID: 29150707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage therapy targeting Escherichia coli-a story with no end?
    Bolocan AS; Callanan J; Forde A; Ross P; Hill C
    FEMS Microbiol Lett; 2016 Nov; 363(22):. PubMed ID: 27974392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophage LM33_P1, a fast-acting weapon against the pandemic ST131-O25b:H4 Escherichia coli clonal complex.
    Dufour N; Clermont O; La Combe B; Messika J; Dion S; Khanna V; Denamur E; Ricard JD; Debarbieux L;
    J Antimicrob Chemother; 2016 Nov; 71(11):3072-3080. PubMed ID: 27387322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific recombination of T2 phage using IP008 long tail fiber genes provides a targeted method for expanding host range while retaining lytic activity.
    Mahichi F; Synnott AJ; Yamamichi K; Osada T; Tanji Y
    FEMS Microbiol Lett; 2009 Jun; 295(2):211-7. PubMed ID: 19453513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adsorption of bacteriophage lambda on the LamB protein of Escherichia coli K-12: point mutations in gene J of lambda responsible for extended host range.
    Werts C; Michel V; Hofnung M; Charbit A
    J Bacteriol; 1994 Feb; 176(4):941-7. PubMed ID: 8106335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophage K1-5 encodes two different tail fiber proteins, allowing it to infect and replicate on both K1 and K5 strains of Escherichia coli.
    Scholl D; Rogers S; Adhya S; Merril CR
    J Virol; 2001 Mar; 75(6):2509-15. PubMed ID: 11222673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of a T4-like phage with a relatively wide host range within Escherichia coli.
    Xu J; Chen M; He L; Zhang S; Ding T; Yao H; Lu C; Zhang W
    J Basic Microbiol; 2016 Apr; 56(4):405-21. PubMed ID: 26697952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Creation of synthetic bacterial viruses].
    Ando H
    Nihon Saikingaku Zasshi; 2018; 73(4):201-210. PubMed ID: 30487377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed Evolution of Replication-Competent Double-Stranded DNA Bacteriophage toward New Host Specificity.
    Liang J; Zhang H; Tan YL; Zhao H; Ang EL
    ACS Synth Biol; 2022 Feb; 11(2):634-643. PubMed ID: 35090114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A T3 and T7 recombinant phage acquires efficient adsorption and a broader host range.
    Lin TY; Lo YH; Tseng PW; Chang SF; Lin YT; Chen TS
    PLoS One; 2012; 7(2):e30954. PubMed ID: 22347414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections.
    Barros J; Melo LDR; Poeta P; Igrejas G; Ferraz MP; Azeredo J; Monteiro FJ
    Int J Antimicrob Agents; 2019 Sep; 54(3):329-337. PubMed ID: 31229670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a Chicken Embryo Lethality Assay to Assess the Efficacy of Phage Therapy.
    Trotereau A; Schouler C
    Methods Mol Biol; 2019; 1898():199-205. PubMed ID: 30570735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Bacteriophage Tail Fiber Interaction with Host Surface Receptor: The Key "Blueprint" for Reprogramming Phage Host Range.
    Taslem Mourosi J; Awe A; Guo W; Batra H; Ganesh H; Wu X; Zhu J
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dispersing biofilms with engineered enzymatic bacteriophage.
    Lu TK; Collins JJ
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11197-202. PubMed ID: 17592147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dispersal network structure and infection mechanism shape diversity in a coevolutionary bacteria-phage system.
    Sieber M; Robb M; Forde SE; Gudelj I
    ISME J; 2014 Mar; 8(3):504-514. PubMed ID: 24088626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Insights into Bacteriophage Evolution toward Its Host.
    de Leeuw M; Baron M; Ben David O; Kushmaro A
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33036277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.